Third Harmonic Bio, Inc.
THRD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $35 | $38 | $0 |
| Gross Profit | -$49 | -$35 | -$38 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $36,500 | $23,964 | $24,407 | $15,748 |
| G&A Expenses | $22,372 | $19,990 | $13,301 | $3,256 |
| SG&A Expenses | $22,372 | $19,990 | $13,301 | $3,256 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$35 | $0 | $0 |
| Operating Expenses | $58,872 | $43,919 | $37,708 | $19,004 |
| Operating Income | $58,872 | -$43,954 | -$37,708 | -$19,004 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$13,403 | $13,130 | $2,553 | -$10,605 |
| Pre-Tax Income | $45,469 | -$30,824 | -$35,155 | -$29,609 |
| Tax Expense | $0 | $0 | $2,553 | $0 |
| Net Income | $45,469 | -$30,824 | -$37,708 | -$29,609 |
| % Margin | – | – | – | – |
| EPS | 1.09 | -0.78 | -0.89 | -0.77 |
| % Growth | 239.7% | 12.4% | -15.6% | – |
| EPS Diluted | 1.09 | -0.78 | -0.89 | -0.77 |
| Weighted Avg Shares Out | 41,730 | 39,645 | 39,377 | 38,694 |
| Weighted Avg Shares Out Dil | 41,730 | 39,645 | 39,377 | 38,694 |
| Supplemental Information | – | – | – | – |
| Interest Income | $13,409 | $13,130 | $3 | $0 |
| Interest Expense | $0 | $0 | $2,553 | $0 |
| Depreciation & Amortization | $49 | $35 | $38 | $19,004 |
| EBITDA | -$45,420 | -$30,789 | -$35,117 | -$10,605 |
| % Margin | – | – | – | – |